1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Dechra Pharmaceuticals PLC
  6. News
  7. Summary
    DPH   GB0009633180

DECHRA PHARMACEUTICALS PLC

(DPH)
  Report
Real-time Estimate Cboe Europe  -  05/17 04:32:00 am EDT
3294.00 GBX   +0.30%
04/26Jefferies Reduces Dechra Pharmaceuticals PT, Keeps Hold Rating
MT
04/08FTSE 100 Closes Higher Led by Mining, Energy Stocks
DJ
03/03DECHRA PHARMACEUTICALS PLC : Ex-dividend day for interim dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Dechra Pharmaceuticals to Appoint New Chairman in January 2022

11/19/2021 | 02:47am EDT


ę MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
DECHRA PHARMACEUTICALS PLC 0.61% 3304 Delayed Quote.-38.33%
ULTRA ELECTRONICS HOLDINGS PLC 0.93% 3258 Delayed Quote.1.51%
ZR (ZR) - CBE (ELECTRONIC)/C1 2.82% 17.86 End-of-day quote.18.73%
All news about DECHRA PHARMACEUTICALS PLC
04/26Jefferies Reduces Dechra Pharmaceuticals PT, Keeps Hold Rating
MT
04/08FTSE 100 Closes Higher Led by Mining, Energy Stocks
DJ
03/03DECHRA PHARMACEUTICALS PLC : Ex-dividend day for interim dividend
FA
02/23WALL STREET STOCK EXCHANGE : Wall Street struggles for direction after cyberattacks
02/23Liberum Lifts Dechra Pharmaceuticals To Hold From Sell
MT
02/23ANALYST RECOMMENDATIONS : Anglo American, BP Plc, Cisco, Intel, Home Depot...
02/22FTSE Russell May Add EasyJet, Drop Dechra Pharmaceuticals From FTSE 100 Index
MT
02/22HSBC Keeps Dechra Pharmaceuticals At Buy, Cuts PT
MT
02/21DECHRA PHARMACEUTICALS : 21 February 2022 Recording of the Analyst Presentation regarding ..
PU
02/21ANALYST RECOMMENDATION : Flutter, Foot Locker, GSK, Nike, On Holding...
More news
Analyst Recommendations on DECHRA PHARMACEUTICALS PLC
More recommendations
Financials
Sales 2022 664 M 813 M 813 M
Net income 2022 77,0 M 94,3 M 94,3 M
Net Debt 2022 162 M 199 M 199 M
P/E ratio 2022 48,3x
Yield 2022 1,34%
Capitalization 3 560 M 4 359 M 4 359 M
EV / Sales 2022 5,60x
EV / Sales 2023 5,08x
Nbr of Employees -
Free-Float 98,6%
Chart DECHRA PHARMACEUTICALS PLC
Duration : Period :
Dechra Pharmaceuticals PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DECHRA PHARMACEUTICALS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 3 284,00 GBX
Average target price 4 842,70 GBX
Spread / Average Target 47,5%
EPS Revisions
Managers and Directors
Ian David Page Chief Executive Officer & Executive Director
Paul Sandland Chief Financial Officer & Executive Director
Alison Elizabeth Platt Chairman
Susan Longhofer Chief Scientific Officer
Allen Mellor Group Director-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
DECHRA PHARMACEUTICALS PLC-38.33%4 359
ZOETIS-32.25%77 809
ELANCO ANIMAL HEALTH INCORPORATED-21.53%10 558
BLUESTAR ADISSEO COMPANY-23.13%3 710
VIRBAC-17.08%3 095
VIMIAN GROUP AB (PUBL)-28.99%2 182